Early diagnosis of Alzheimer dementia based on clinical and biological factors

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL. 3, 1999, Pages

  Almkvist, Ove ^a   Winblad, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Biological; Clinical; Markers

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; TAU PROTEIN;

AGE; ALZHEIMER DISEASE; AMNESIA; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; CONFERENCE PAPER; DEMENTIA; DISEASE COURSE; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; GENDER; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR;

EID: 0343415645     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014171     Document Type: Conference Paper

References (67)

1. Almkvist O, Bäckman L (1996) Detection and staging of early clinical dementia. Acta Neurol Scand 88:10-15
2. Almkvist O (1996) Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl 165: 21-29
3. Almkvist O, Basun H, Bäckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B (1998) Mild cognitive impairment - an early stage of Alzheimer's disease? J Neural Transm Suppl 54: 21-29
4. Andreassen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K (1998) Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry 64: 298-305
5. (1-42) in Alzheimer's disease: differences between early- and late-onset AD and stability during the course of the disease. Arch Neurol
6. Arnaiz E, Blomberg M, Fernaeus SE, Wahlund LO, Almkvist O (1999) Psychometric discrimination of mild cognitive impairment and Alzheimer's disease. Submitted
7. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17: 263-264
8. Benton AL, Hamsher K, Varney NR, Spreen O (1983) Contributions to Neuropsychological Assessment. New York: Oxford University Press
9. Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO (1996) Increasing cerebrospinal tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele e4 during 14 months follow-up. Neurosci Lett 214: 163-166
10. Corder EH, Lannfelt L, Bogdanovic N, Fratiglioni L, Mori H (1998) The role of APOE polymorphism in late-onset dementias. Cell Mol Life Sci 54: 928-934
11. Davidson P, Jahn R, Bergquist J, Ekman R, Blennow K (1996) Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer's disease. Mol Chem Neuropath 27: 195-210
12. Dawe B, Proctor A, Philpot M (1992) Concepts of mild memory impairment in the elderly and their relationship to dementia: a review. Int J Geriatr Psychiatry 42: 473-479
13. De Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T De Santi S, Smith G, Ferris SH, Noz M (1993) The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiol 14: 897-906
14. De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, De Santi S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC, Wisniewski HM (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 18: 1-11
15. Dierks T, Jelic V, Julin P, Maurer K, Wahlund LO, Almkvist O, Strik WK, Winblad B (1997) EEG-micro states in mild memory impairment and Alzheimer's disease: possible association with disturbed information processing. J Neural Transm [Gen Sect] 99: 55-62
16. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiology 138: 353-364
17. Fratiglioni L (1998) Epidemiology. In: A Wimo, B Jönsson, K Karlsson, B Winblad (eds), Health Economics of Dementia. New York: John Wiley & Sons, pp13-31
18. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles R, Boss MA, Seubert P (1998) High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer's disease and relation to apolipoprotein E genotype. Arch Neurol 55: 937-945
19. Galasko D, Motter R, Seubert P (1996) Interpreting cerebrospinal fluid tau levels in Alzheimer's disease. Neurobiol Aging 17: S1
20. George MS, Ketter TA, Post RM (1993) SPECT and PET imaging in mood disorders. J Clin Psychiatry 54 (Suppl 11): 6-13
21. Guo Z, Viitanen M, Fratiglioni L, Winblad B (1996) Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 312: 805-808
22. Growdon JH (1999) Biomarkers of Alzheimer's disease. Arch Neurol 56: 281-283
23. Haxby JV, Grady CL, Koss E, Horowitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47: 753-760
24. Herholz K (1995) FDG PET and differential diagnosis of dementia. Alz Dis Assoc Disord 1:6-16
25. Herlitz A, Small BL, Fratiglioni L, Almkvist O, Bäckman L (1997) Detection of mild dementia in community surveys: is it possible to increase accuracy of our diagnostic instruments? Arch Neurol 54: 319-324
26. Ida N, Hartmann T, Pantel J, Schröder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, Beyreuther K (1996) Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 271: 22908-22914
27. Jack CJ, Petersen RC, O'Brian PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42: 183-188
28. Jagust WJ (1994) Functional imaging in dementia: an overview. J Clin Psychiatry 55 (Suppl): 5-11
29. Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund LO (1996) Quantitative electroencephalography power and coherence in Alzheimer's Disease and Mild Cognitive Impairment. Dementia 7: 314-323
30. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Winblad B, Wahlund LO (submitted) Quantitative EEG in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease
31. Jensen M, Basun H, Lannfelt L (1995) Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neurosci Lett 186: 189-191
32. Jensen M, Blomberg M, Engwall B, Hartmann T, Axelman K, Basun H, Beyreuther K, Wahlund LO, Lannfelt L (1999) Decreased levels of cerebrospinal fluid Aβ42 in Alzheimer's disease compared to vascular and frontotemporal lobe dementias. Submitted
33. Jensen M, Schröder J, Blomberg M, Engwall B, Pantel J, Ida N, Basun H, Wahlund LO, Werle E, Jauss M, Beyreuther K, Lannfelt L, Hartmann T (1999) Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol 45: 504-511
34. Jorm AF (1990) The epidemiology of Alzheimer's disease and related disorders. London: Chapman and Hall
35. Julin P, Almkvist O, Basun H, Lannfelt L, Svensson L, Winblad B, Wahlund LO (1998) Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid mutation. Alz Dis Assoc Disord 12: 49-53
36. Julin P, Kristiansson S, Jelic V, Shigeta M, Almkvist O, Lindqvist J, Svensson L, Slomka P, Wahlund LO (submitted) MRI/ SPECT imaging of regional brain atrophy and blood flow reduction in mild cognitive impairment and Alzheimer's disease.
37. Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarebarayashi T, ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, Aβ40 and Aβ42(43) in Alzheimer's disease in Japan. Ann Neurol 44: 17-26
38. Katzman R (1993) Education and the prevalence of dementia and Alzheimer's disease. Neurology 43: 13-20
39. Kurz A, Riemenschneider M, Buch K, Willoch F, Bartenstein P, Muller U, Guder W (1998) Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer's disease. Alz Dis Assoc Disord 12: 372-377
40. Lannfelt L (1996) Genetics of Alzheimer's disease. Acta Neurol Scand Suppl 168: 25-27
41. rd ed. New York: Oxford University Press
42. Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 33: 494-501
43. Molina L, Touchon J, Lefranc D, vermesch P, Pau B, Mourton-Gilles C (1996) Detection of tau proteins in cerebrospinal fluids from Alzheimer's patients. Neurobiol Aging 17: S166
44. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 38: 643-648
45. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules (1993) Neurology 43: 2412-2414
46. Nordberg A (1993) Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 57: 215-224
47. Nuwer M (1997) Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neuropshysiological Society. Neurology 49: 277-292
48. Passero S, Rocchi R, Vatti G, Burgalassi L, Battistini N (1995) Quantitative EEG mapping, regional cerebral blood flow, and neuropsychological function in Alzheimer's disease. Dementia 6: 148-156
49. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308
50. Primavera A, Novello P, Finocchi C, Canevari E, Corsello L (1990) Correlation between Mini Mental State Examination and quantitative EEG in senile dementia of Alzheimer type. Neuropsychobiology 23: 74-78
51. Reisberg B, Ferris S, deLeon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 130: 1136-1139
52. Rosen I (1997) Electroencephalography as a diagnostic tool in dementia. Dement Geriatr Cogn Disord 8: 110-116
53. Saletu B, Anderer P, Paulus E, Grunberger J, Wicke L, Neuhold A, Fishhof PK, Litschauer G (1991) EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alz Dis Assoc Disord 5 (Suppl 1): S57-S75
54. Seab JP, Jagust WJ, Wong ST, Roos MS, Reed BR, Budinger TF (1988) Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 8: 200-208
55. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55: 967-972
56. Storandt M, Hill R (1989) Very mild senile dementia of the Alzheimer type: II. Psychometric test performance. Arch Neurol 46: 383-386
57. Tamaoka A, Kondo T, Odaka A, Sahara N, Sawamura N, Ozawa K, Suzuki N, Shoji S, Mori H (1994) Biochemical evidence for the long-tail form (Aβ 1-42/43) of amyloid β protein as a seed molecule cerebral depositis for Alzheimer's disease. Biochem Biophys Res Commun 205: 834-842
58. Tato RA, Frank A, Hernanz A (1995) Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 59: 280-283
59. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St Georges-Hyslop PH. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46: 661-665
60. Wahlund LO, Andersson-Lundman G, Basun H, Almkvist O, Bjorksten KS, Saaf J, Wetterberg L (1993) Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy controls. Magn Reson Imaging 11: 169-174
61. Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L (in press) A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dement Geriatr Cogn Disord
62. Waldemar G (1995) Functional brain imaging with SPECT in normal aging and dementia: methodological, pathophysiological, and diagnostic aspects. Cerebrovas Brain Met 7: 89-130
63. (1-42) in cerebrospinal fluid as biochemical markers for Alzheimer's disease. Submitted
64. Wechsler D (1981) Wechsler Adult Intelligence Scale, Revised (WAIS-R): Manual. New York: Psychological Corporation
65. Weinstein HC, Scheltens P, Hijdra A, van Royen EA (1993) Neuroimaging in the diagnosis of Alzheimer's disease. II Positron and single photon emission tomography. Clin Neurol Neurosurg 95: 81-91
66. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1991) Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 48: 278-281
67. Wszolek ZK, Herkes GK, Lagerlund TD, Kokmen E (1992) Comparison of EEG background frequency analysis, psychological test scores, short tests of mental status, and quantitative SPECT in dementia. J Geriatr Psychiatr Neurol 5: 22-30